Pharmacy Society of Wisconsin
Registered Principal Details
Business Or Interest:
Pharmacy, pharmacists, pharmacy technician, student pharmacists, schools of pharmacy, pharmaceuticals, healthcare
Lobbying Interests:
Issues affecting pharmacists, pharmacy technicians, pharmacy students, pharmacy residents, pharmacy businesses, medication usage, medication costs, prescription drug use, medication use and abuse, and the practice of pharmacy.
CEO Name:
Sarah Sorum
Pharmacy, pharmacists, pharmacy technician, student pharmacists, schools of pharmacy, pharmaceuticals, healthcare
Lobbying Interests:
Issues affecting pharmacists, pharmacy technicians, pharmacy students, pharmacy residents, pharmacy businesses, medication usage, medication costs, prescription drug use, medication use and abuse, and the practice of pharmacy.
CEO Name:
Sarah Sorum
Contact
DMW
Danielle M Womack
701 Heartland Trail
Madison, WI 53717
(608) 827-9200
dwomack@pswi.org
http://www.pswi.org
701 Heartland Trail
Madison, WI 53717
(608) 827-9200
dwomack@pswi.org
http://www.pswi.org
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Administrative Rulemaking Proceedings
Agency Name
Pharmacy Examining Board (Phar)
Subject
Compounding pharmaceuticals
Scope Statement
SS 007_23
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Pharmacy Examining Board (Phar)
Subject
Compounding pharmaceuticals
Scope Statement
SS 007_23
Other
Notification Date1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Agency Name
Pharmacy Examining Board (Phar)
Subject
Controlled substances requirements
Scope Statement
SS 044_23
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Pharmacy Examining Board (Phar)
Subject
Controlled substances requirements
Scope Statement
SS 044_23
For
Notification Date1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Electronic prescriptions, prescription labeling, CPR for pharmacists, epinephrine delivery systems, controlled substance prescription transfers, remote dispensing, managing pharmacist definition, initial consultation, alteration, and final check
Agency Name
Pharmacy Examining Board (Phar)
Subject
Electronic prescriptions, prescription labeling, CPR for pharmacists, epinephrine delivery systems, controlled substance prescription transfers, remote dispensing, managing pharmacist definition, initial consultation, alteration, and final check
Scope Statement
SS 089_24
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Pharmacy Examining Board (Phar)
Subject
Electronic prescriptions, prescription labeling, CPR for pharmacists, epinephrine delivery systems, controlled substance prescription transfers, remote dispensing, managing pharmacist definition, initial consultation, alteration, and final check
Scope Statement
SS 089_24
Undisclosed
Notification Date1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Agency Name
Pharmacy Examining Board (Phar)
Subject
Pharmacy workplace conditions
Scope Statement
SS 002_25
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Pharmacy Examining Board (Phar)
Subject
Pharmacy workplace conditions
Scope Statement
SS 002_25
Undisclosed
Notification Date1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Access to opioid reversal agents
Access to opioid reversal agents
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/31/2025
First Communication Date
1/28/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Both Legislative matter and rule
Notification Date
1/31/2025
First Communication Date
1/28/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Development, drafting or introduction of a proposal relating to
Pharmacist prescribing of contraception
Pharmacist prescribing of contraception
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative matter and rule
Notification Date
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Pharmacy practice
Pharmacy practice
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative matter and rule
Notification Date
1/23/2025
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
PBM reform
PBM reform
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/23/2025
First Communication Date
1/14/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Both Legislative matter and rule
Notification Date
1/23/2025
First Communication Date
1/14/2025
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Total Lobbying Effort
No certified reports found.
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
No legislative bills/resolutions found.
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
No topics found.
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.